NO20045722L - Kontrollsekvenser for det humane corin-genet - Google Patents

Kontrollsekvenser for det humane corin-genet

Info

Publication number
NO20045722L
NO20045722L NO20045722A NO20045722A NO20045722L NO 20045722 L NO20045722 L NO 20045722L NO 20045722 A NO20045722 A NO 20045722A NO 20045722 A NO20045722 A NO 20045722A NO 20045722 L NO20045722 L NO 20045722L
Authority
NO
Norway
Prior art keywords
control sequences
control region
human corin
corin gene
gene
Prior art date
Application number
NO20045722A
Other languages
English (en)
Norwegian (no)
Inventor
Qingyu Wu
Junliang Pan
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20045722L publication Critical patent/NO20045722L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20045722A 2002-05-31 2004-12-30 Kontrollsekvenser for det humane corin-genet NO20045722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38410802P 2002-05-31 2002-05-31
PCT/US2003/016741 WO2003102135A2 (en) 2002-05-31 2003-05-28 Control sequences of the human corin gene

Publications (1)

Publication Number Publication Date
NO20045722L true NO20045722L (no) 2004-12-30

Family

ID=29711979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045722A NO20045722L (no) 2002-05-31 2004-12-30 Kontrollsekvenser for det humane corin-genet

Country Status (18)

Country Link
US (1) US20030223976A1 (cg-RX-API-DMAC7.html)
EP (1) EP1546172A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005531302A (cg-RX-API-DMAC7.html)
KR (1) KR20050009724A (cg-RX-API-DMAC7.html)
CN (1) CN1671729A (cg-RX-API-DMAC7.html)
AU (1) AU2003245342A1 (cg-RX-API-DMAC7.html)
BR (1) BR0311603A (cg-RX-API-DMAC7.html)
CA (1) CA2487024A1 (cg-RX-API-DMAC7.html)
CR (1) CR7622A (cg-RX-API-DMAC7.html)
EC (1) ECSP045518A (cg-RX-API-DMAC7.html)
IL (1) IL165244A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04011944A (cg-RX-API-DMAC7.html)
NO (1) NO20045722L (cg-RX-API-DMAC7.html)
PL (1) PL374125A1 (cg-RX-API-DMAC7.html)
RS (1) RS104404A (cg-RX-API-DMAC7.html)
RU (1) RU2004139055A (cg-RX-API-DMAC7.html)
WO (1) WO2003102135A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200410400B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026255A1 (en) * 2002-06-25 2005-02-03 Morser John Michael Corin, a serine protease
WO2005084223A2 (en) * 2004-02-27 2005-09-15 The General Hospital Corporation Methods and compositions for hair growth
CN101321727B (zh) 2005-12-01 2013-03-27 西巴控股有限公司 肟酯光敏引发剂
US20110306069A1 (en) 2009-02-19 2011-12-15 Qingyu Wu Corin As A Marker For Heart Failure
CN105734070A (zh) * 2016-04-11 2016-07-06 苏州大学 Corin基因变异体及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917123A (en) * 1997-03-14 1999-06-29 University Of Pittsburgh Transgenic mice containing a nucleic acid encoding tumor necrosis factor-α under the control of a cardiac specific regulatory region
ES2307338T3 (es) * 1998-06-05 2008-11-16 Bayer Schering Pharma Aktiengesellschaft Corina, una serina proteasa.
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU2001233262A1 (en) * 2000-02-03 2001-08-14 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2001245671A (ja) * 2000-03-07 2001-09-11 Chiba Prefecture ヒト神経芽細胞腫においてクローニングされた新規遺伝子及び新規遺伝子の断片

Also Published As

Publication number Publication date
KR20050009724A (ko) 2005-01-25
IL165244A0 (en) 2005-12-18
BR0311603A (pt) 2005-06-07
AU2003245342A1 (en) 2003-12-19
RU2004139055A (ru) 2005-08-20
RS104404A (sr) 2006-12-15
WO2003102135A2 (en) 2003-12-11
EP1546172A4 (en) 2005-11-30
CA2487024A1 (en) 2003-12-11
JP2005531302A (ja) 2005-10-20
WO2003102135A3 (en) 2004-11-04
US20030223976A1 (en) 2003-12-04
ECSP045518A (es) 2005-03-10
CN1671729A (zh) 2005-09-21
ZA200410400B (en) 2006-06-28
PL374125A1 (en) 2005-10-03
EP1546172A2 (en) 2005-06-29
CR7622A (es) 2006-05-29
MXPA04011944A (es) 2005-03-31

Similar Documents

Publication Publication Date Title
EP2465921A3 (en) Cardiac stem cells from biopsy
Re The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues
MXPA02007137A (es) Fuente de tejido hepatico.
DK1028737T3 (da) Humane mesenchymale stamceller fra perifert blod
WO2004009767A3 (en) Cell therapy for regeneration
MX2007006524A (es) Metodos para el suministro dirigido de material genetico al higado.
DK1019082T3 (da) Fremgangsmåde til moduleringen af neovaskularisering og/eller væksten af kollaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
CA2358439A1 (en) Metastasis models using green fluorescent protein (gfp) as a marker
SG166672A1 (en) Methods of down regulating target gene expression in vivo by introduction of interfering rna
WO2002012440A3 (en) Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
EP1362510A3 (en) A mouse model for hepatocellular carcinoma by targeted integration of hepatitis B virus genes
WO2003102135A3 (en) Control sequences of the human corin gene
WO2003027633A3 (en) Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
EP2914300B1 (en) Light-sensitive ion channels for induction of cardiac activity
Gupta et al. Epidemiology of melanoma
Barton-Burke et al. Cancer therapies
KR20240032905A (ko) 색소침착을 감소시키기 위한 조성물 및 방법
DE602005025341D1 (de) Verfahren zum selektiven expandieren, auswählen und anreichern von stamm- bzw. vorläuferzellen-populationen
GB0211459D0 (en) Plasmid stabilisation in vivo
DES JACOBINS et al. International Scientific Committee
Chen et al. 1277 Melanoma outcomes at a US regional veterans hospital vs an academic institution by AJCC and SEER staging, 1985-2022
Vaddi et al. 1278 Blocking tumor-intrinsic caspase-1 inflammasome sensitizes melanoma response to anti-PD1 therapy by rejuvenating dysfunctional CD8 T cells
Germán et al. 1276 Morphologic variants of cell cannibalism in the spontaneous human melanoma-fibroblast hybrids using high-content fluorescent microscope imaging
Kemény et al. 1279 MITF-regulates cellular ROS levels in cutaneous melanoma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application